NANCY HESSE was named president and CEO of the Cancer Treatment Centers of America Eastern Regional Medical Center (Eastern) in Philadelphia. Hesse has served as interim president and CEO since February 2016, and before that as chief nursing executive for CTCA and chief nursing officer at Eastern. Hesse joined CTCA in 2014 after a long […]
GEORGE WASHINGTON UNIVERSITY has formally launched the GW Cancer Center. The GW Cancer Center is a collaboration between GW Hospital, The GW Medical Faculty Associates, the GW School of Medicine and Health Sciences, and the Milken Institute School of Public Health at GW, to expand GW’s efforts in the fight against cancer. The GW Cancer […]
THE PARKER INSTITUTE for Cancer Immunotherapy and the Cancer Research Institute announced a Collaboration focused on neoantigens. The search for these unique cancer markers has become a robust area of research as scientists believe they may hold the key to developing a new generation of personalized, targeted cancer immunotherapies. The collaboration, the Tumor neoantigEn SeLection […]
UT Health Northeast in Tyler, TX, and MD Anderson Cancer Center announced a partnership to provide greater access to the most advanced cancer care available for adult patients in northeast Texas and the surrounding region. Through the partnership, UT Health Northeast’s Cancer Treatment and Prevention Center joins MD Anderson Cancer Network, an international collaboration of […]
The American College of Radiology board of selected three innovators as 2017 Gold Medalists for their extraordinary service to the college or radiology. Honors will be presented bestowed during ACR 2017 – The Crossroads of Radiology meeting in Washington May 21-25, 2017. The following individuals will receive the ACR Gold Medal: Bruce Hillman, of Wake […]
THE ROYAL NETHERLANDS Academy of Arts and Sciences named cancer researcher Bert Vogelstein as the very first recipient of the KNAW Bob Pinedo Cancer Care Award. In the 1980s, Vogelstein demonstrated the genetic mechanism that leads to cancer. He is now working on cancer therapies that utilize the patient’s immune system. He is also developing […]
MILTON BROWN was named director of the new Inova Center for Drug Discovery and Development and as deputy director for drug discovery for the Inova Schar Cancer Institute. Brown is one of a handful of physician scientists in the United States who hold a Ph.D. in synthetic chemistry and an M.D. He will bring his […]
JOSHUA COLEMAN was named vice president of medical affairs at GenomOncology. He will oversee clinical content development and curation of scientific evidence, enhancing the company’s proprietary knowledge-enabled platform. The GenomOncology software suite empowers molecular pathologists with a seamless workflow for the interpretation of genetic sequencing data and clinical decision support, from quality control through reporting. […]
TEMPUS, a technology company focused on supporting physicians delivering customized cancer care, and the University of Pennsylvania Abramson Cancer Center partnered to better determine which patients will have a positive response to immunotherapy treatment based on next generation genomic and transcriptomic sequencing. As part of a research collaboration, Tempus will provide sequencing and analysis of […]
AMGEN and Allergan plc submitted a Marketing Authorization Application to the European Medicines Agency for ABP 215, a biosimilar candidate to Avastin (bevacizumab). The companies said they this submission is the first bevacizumab biosimilar application submitted to the EMA. ABP 215 is a biosimilar candidate to bevacizumab, a recombinant immunoglobulin G1 monoclonal antibody that binds […]
